Valuation: Baxter International Inc.

Market Cap 12.16B 10.6B 10.03B 9.11B 17.02B 1,165B 17.11B 119B 46.19B 592B 45.7B 44.68B 1,895B P/E 2026 *
30.2x
P/E 2027 * 19.6x
Enterprise Value 19.06B 16.6B 15.71B 14.28B 26.67B 1,826B 26.8B 187B 72.37B 928B 71.61B 70.01B 2,970B EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.56x
Free-Float
75.39%
Yield 2026 *
0.17%
Yield 2027 * 0.17%
1 day-1.98%
1 week-4.40%
Current month-11.10%
1 month-10.79%
3 months+19.21%
6 months+31.19%
Current year+20.96%
1 week 23.1
Extreme 23.105
24.77
1 month 23.1
Extreme 23.105
26.78
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Chief Tech/Sci/R&D Officer 57 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
9/1/26 Tax

President, CCS

-750 0.0001% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-4.40%-0.37%-40.32% 12.16B
+0.03%-0.78%-23.56%+1.54% 177B
+0.65%+1.69%-1.49%+12.52% 118B
-2.88%-3.01%+7.68%+73.88% 60.78B
-0.09%+3.35%-2.80%-31.09% 49.53B
+1.18%-2.39%+4.57%+35.50% 48.29B
+0.81%+4.01%+14.99%-7.76% 32.96B
-2.50%+0.22% - - 28.94B
+1.16%+6.92%+43.41%-6.73% 25.48B
+1.13%+2.89%+11.87%-22.76% 21.77B
Average -0.23%+0.14%+6.03%+1.64% 57.55B
Weighted average by Cap. -0.06%-0.61%-3.56%+9.16%

Financials

2026 *2027 *
Net sales 11.62B 10.12B 9.58B 8.7B 16.26B 1,113B 16.34B 114B 44.11B 565B 43.64B 42.67B 1,810B 11.86B 10.33B 9.78B 8.89B 16.6B 1,136B 16.68B 116B 45.04B 577B 44.57B 43.58B 1,848B
Net income 372M 324M 307M 279M 521M 35.63B 523M 3.65B 1.41B 18.11B 1.4B 1.37B 57.96B 687M 599M 567M 515M 962M 65.84B 967M 6.75B 2.61B 33.46B 2.58B 2.53B 107B
Net Debt 6.9B 6.01B 5.69B 5.17B 9.65B 661B 9.7B 67.72B 26.19B 336B 25.91B 25.33B 1,075B 6.32B 5.5B 5.21B 4.73B 8.84B 605B 8.88B 62.02B 23.98B 307B 23.73B 23.2B 984B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-17 US$23.13 -1.70% 3,911,793
26-09-16 US$23.53 -0.76% 9,453,579
26-09-15 US$23.71 -0.63% 6,145,777
26-09-14 US$23.86 +0.25% 5,741,921
26-09-11 US$23.80 -1.57% 5,450,645
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
23.53USD
Average target price
28.73USD
Spread / Average Target
+22.09%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!